•An in silico clinical trial is underway with the 3DEXPERIENCE platform to evaluate the Living Heart simulated 3D heart for transforming how new devices can be tested •Five-year extension of their collaborative research agreement aims to spur medical device innovation by enabling innovative, new product designs •Both Dassault Systèmes and the FDA recognize the transformative impact of modeling and simulation on public health and patient safety

•Dassault Systèmes collaborated with SATS, Asia’s leading food solutions and gateway services provider, to boost operational efficiency, minimize food waste •Growth in airline passenger travel underscores need for sustainable excellence in aerospace industry-related commercial services •Digital twin experience with the 3DEXPERIENCE platform bridges the gap between the virtual and real for in-flight catering production

•Annual event in Shanghai gathers global decision-makers to discuss digital trends, insights and best practices for sustainable manufacturing in the Industry Renaissance •Speakers include thought leaders from ABB, Accenture, China Center for Information Industry Development, FAW Group Corporation, Huawei, IDC, SATS •Interactive workshops featuring the 3DEXPERIENCE platform highlight the transformative role of virtual worlds on the creation of new customer experiences

VÉLIZY-VILLACOUBLAY, France — October 24, 2019 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA) announces IFRS unaudited financial results for the third quarter and nine months ended September 30, 2019. These results were reviewed by the Group’s Board of Directors on October 23, 2019. This press release also includes financial information on a non-IFRS basis with reconciliations included in the Appendix to this communication. All IFRS and non-IFRS figures are presented in compliance...

VÉLIZY-VILLACOUBLAY, France and NEW YORK, United States of America — October 24, 2019 – Dassault Systèmes SE ("Dassault Systèmes") (Euronext Paris: #13065, DSY. PA) and Medidata Solutions, Inc. ("Medidata") (NASDAQ: MDSO) announced that the Committee on Foreign Investment in the United States ("CFIUS") approved the proposed acquisition of Medidata by Dassault Systèmes. Receipt of CFIUS clearance was one of the final conditions to the merger. In accordance with the...

• The 3DEXPERIENCE Platform combines modeling, simulation, data science, artificial intelligence and collaboration in the virtual world to achieve sustainable innovation in life sciences • Dassault Systèmes, together with Medidata Solutions, will lead the digital transformation of life sciences in the age of personalized medicine and patient-centric experience • Connecting the 3DEXPERIENCE Platform with Medidata’s Clinical Trial platform connects the dots between research, development,...

VELIZY-VILLACOUBLAY, France — November 13th, 2019 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA) is holding a Life Sciences Day for analysts and investors, today, Wednesday, November 13th, 2019 starting at 09.00 am ET in New York. The event includes presentations by the senior executive management team. The sessions are being webcast live and will be available for replay by accessing https://investor.3ds.com/events/event-details/life-sciences-day. Bernard Charlès, Dassault Systèmes’ Vice...

•Survey of 3,000 consumers in the U.S., China and France examines views on personalization in healthcare, mobility, retail, and home and city environments •Personalization in healthcare, prioritized over other categories, will require AI, 5G and home assistant technologies to achieve, according to respondents •Consumers will pay on average 25.3% more for personalization, but they expect a savings in return •Generation X, millennials, and Generation Z are more willing to pay and share data...

BIOVIA Direct

BIOVIA Direct

BIOVIA Workbook 2019

BIOVIA Workbook 2019

ASP.NET Core version 5.-RC1 suffers from an HTTP header injection vulnerability.